BackLyell Immunopharma Overview

Lyell Immunopharma Total Liabilities

Track Lyell Immunopharma's total liabilities ($77M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$76.96M
↓ 17.49% YoYΔ $-16.32M vs prior year quarter

Peer average

Loading

Lyell Immunopharma Total Liabilities History

Loading

Lyell Immunopharma vs. peers: Total Liabilities Comparison

Loading

Lyell Immunopharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lyell Immunopharma (LYEL) FAQ

As of the most recent data (March 2026), LYEL shows a total liabilities of $77M. That compares with $93M in the prior-year period — down 17.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYEL's total liabilities is now $77M (was $93M) — a 17.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lyell Immunopharma is outperforming or lagging.

Tracking LYEL's total liabilities over time shows whether Lyell Immunopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $77M That compares with $93M in the prior-year period — down 17.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Lyell Immunopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $77M) with ownership activity and broader fundamentals.

Lyell Immunopharma's total liabilities is $77M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.